This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pharmazz, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bhawna Katia: Innovator in Medical Research
Introduction
Bhawna Katia is a prominent inventor based in Bathinda, India. She has made significant contributions to the field of medical research, particularly in understanding the alterations in endothelin receptors following hemorrhage and resuscitation.
Latest Patents
Bhawna holds a patent titled "Alterations in Endothelin Receptors Following Hemorrhage and Resuscitation by Centhaquin." This patent reflects her innovative approach to addressing critical medical challenges.
Career Highlights
Bhawna is currently associated with Pharmazz, Inc., where she continues to advance her research and development efforts. Her work is pivotal in exploring new therapeutic avenues in medicine.
Collaborations
Bhawna collaborates with Anil Gulati, enhancing the scope and impact of her research initiatives.
Conclusion
Bhawna Katia's contributions to medical research through her patent and work at Pharmazz, Inc. highlight her role as an influential inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile